UK Pharmacy GDP — What MHRA Inspectors Actually Look For

Why GDP became the binding compliance for UK pharmacy supply

Good Distribution Practice (GDP) governs the wholesale and storage of medicinal products in the UK. The MHRA enforces it under the Human Medicines Regulations 2012 and the EU GDP Guidelines (which the UK retained post-Brexit with minor modifications). Any pharmacy holding a Wholesale Dealer Licence (WDA(H)) is subject to MHRA GDP inspections; community pharmacies that wholesale to other healthcare providers are increasingly being inspected even where the wholesaling is incidental to the primary dispensing activity.

This post walks through what MHRA inspectors actually look for during a UK pharmacy GDP inspection, where typical operations fall short, and what a defensible posture looks like.

The 9 GDP themes inspectors examine

1. Quality system. Documented standard operating procedures (SOPs) covering every aspect of medicine handling. Not just having SOPs — having SOPs that are current, signed by the Responsible Person (RP), and demonstrably followed.

2. Personnel. The Responsible Person named on the WDA(H) must be in post, qualified (typically GPhC-registered pharmacist with documented GDP training), and demonstrably involved in operations.

3. Premises and equipment. Temperature-controlled storage with continuous monitoring, calibration of monitoring equipment, secure storage for controlled drugs, segregated storage for returned / quarantined / recalled medicines.

4. Documentation. Inspections want to see complete records of receipt, storage, distribution, returns, recalls, complaints, and deviations. The records must be retrievable on request — typically within 1-2 hours, not days.

5. Operations. SOPs covering procurement (only from approved suppliers), receipt (with verification), storage (temperature, segregation), picking, packing, dispatch, and customer-side verification.

6. Complaints, returns and recalls. Documented procedures with named accountabilities, including the recall workflow that pulls products from downstream customers and manages the return logistics.

7. Outsourced activities. If you outsource any GDP activity (delivery, storage, repackaging) the contracts must specify GDP responsibilities clearly.

8. Self-inspection. Annual internal audit against the GDP standard, with findings logged and corrective actions tracked.

9. Transportation. Cold-chain medicines transported in validated cold containers; ambient temperature shipments documented; data logger evidence available.

Where typical UK pharmacy operations fall short

Temperature monitoring is incomplete. A digital fridge thermometer that nobody checks counts as monitoring on paper, but inspectors test calibration and look for continuous data — not spot-check sticky notes. Most pharmacies have the hardware but don't have the audit trail.

Documentation lives in multiple systems. Receipt records in the wholesaler portal, dispensing records in the PMR, complaint records in email, recall records in a binder. When inspectors ask for "the complete record for this lot," staff hunt across systems and the assembly takes hours.

SOPs are out of date. The SOP for cold-chain receipt was written in 2018 by a previous RP; current staff follow a different workflow. Inspectors compare written SOP to actual practice and findings result.

Self-inspection is checkbox-only. Annual self-inspection completed by ticking boxes on a template; no real review, no findings, no corrective action. Inspectors recognise the pattern and dig deeper.

Outsourced delivery without GDP terms. Pharmacy uses a courier for delivery to other pharmacies. Courier contract doesn't reference GDP. Cold-chain breach during delivery becomes pharmacy's problem.

What a defensible MHRA posture looks like

A pharmacy that's MHRA-inspection-ready can produce, on demand:

• A current SOP manual signed by the RP within the last 12 months
• Complete temperature monitoring data for all controlled storage for the last 6+ months
• Calibration certificates for monitoring equipment within the last 12 months
• The RP's GDP training records and the dates training was last refreshed
• Receipt records (with supplier verification) for the last 6 months of inbound product
• Distribution records (with customer verification) for the last 6 months of outbound
• Complete recall records including downstream customer notification and return verification
• Annual self-inspection report with findings + corrective actions tracked

Most UK pharmacy GDP findings result from missing or incomplete versions of the above — not from sophisticated quality issues.

The cold-chain specific discipline

Refrigerated medicines (insulin, vaccines, certain biologics) require continuous 2-8°C with documented monitoring. The discipline:

• Continuous-recording dataloggers in every fridge (not just a thermometer)
• Daily check that the data has been recorded (gap = investigate)
• Out-of-range alarm with 24/7 response procedure
• Validated cold-chain containers for any inter-pharmacy transfer
• Calibration of dataloggers annually with traceable certificate

Cold-chain failures discovered during inspection are escalated above other GDP findings because patient harm is direct.

Where ShelfLifePro fits for UK pharmacy GDP

ShelfLifePro captures lot at receipt, integrates with leading temperature dataloggers (Vaisala, Tinytag, Comark), maintains the SOP-aligned audit trail with timestamp + user, supports the complete recall workflow with customer notification, and produces the MHRA-format records on demand. Not a replacement for your PMR — a compliance / inventory layer that sits alongside.

Free 14-day trial.

Related reading

• DSCSA pedigree requirements 2026 (US analog)
• Cold chain temperature logs grocery
• Product recall first 24 hours
• Hospital outpatient pharmacy mixed pool